- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER-2 Positive Advanced Gastric Cancer
Total 1059 results
-
SCRI Development Innovations, LLCGlaxoSmithKlineTerminatedHER2 Positive Esophagogastric CancerUnited States
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingER Positive/HER2 Low Breast CancerChina
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Organisation for Oncology and Translational ResearchUnknownLetrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal WomenER Positive, HER2 Negative Breast CancerChina
-
Yu jirenRecruitingHER2-positive Gastric Cancer | Adenocarcinoma of the Stomach | Adenocarcinoma of Esophagogastric JunctionChina
-
VelosBio Inc.CompletedGastric Cancer | Pancreatic Cancer | NSCLC | Platinum-resistant Ovarian Cancer | Triple-negative Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Non-squamous Non-small-cell Lung Cancer | Estrogen-receptor-positive Breast Cancer | Progesterone-receptor-positive Breast Cancer | Estrogen-receptor-negative... and other conditionsUnited States, Canada
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedER+ / HER2- Advanced Breast CancerChina
-
Yonsei UniversityNot yet recruitingHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Stemline Therapeutics, Inc.CompletedAdvanced ER+, HER2-Negative Breast CancerUnited States
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerGermany
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingER-Positive, HER2-Negative Breast CancerChina
-
AstraZenecaQuotient SciencesCompletedER-positive, HER2-negative Breast CancerUnited Kingdom
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast CancerUnited States
-
Huashan HospitalSeattle Integrative Cancer CenterUnknownMetastatic Gastric Cancer | Locally Advanced Gastric CancerChina, United States
-
Washington University School of MedicineUnited States Department of Defense; Aclaris Therapeutics, Inc.Not yet recruitingHormone Receptor Positive HER-2 Negative Metastatic Breast CancerUnited States
-
MacroGenicsApproved for marketingHER2-positive Breast Cancer | HER2-positive Carcinoma
-
Shenzhen Yangli Pharmaceutical Technology Co., LtdRecruitingMetastatic Breast Cancer | ER+, HER2- Advanced Breast CancerChina
-
Astellas Pharma Global Development, Inc.AvailableMetastatic Gastroesophageal Junction (GEJ) Adenocarcinoma | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma Cancer | Metastatic Gastric Adenocarcinoma CancerUnited States, Germany
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTargeted Therapy | HR+/HER2- Advanced Breast CancerChina
-
Beta Pharma (Suzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | HR+/HER2- Breast CancerChina
-
Novartis PharmaceuticalsCompletedHR+/HER2- Advanced or Metastatic Breast CancerIreland
-
Krankenhaus NordwestCompletedAdvanced Gastric Cancer | Esophagogastric Junction CancerGermany
-
UNICANCERWithdrawnER-positive Her2-negative Early Breast Cancer
-
KU LeuvenNovartisUnknownER Positive, HER2 Negative Breast Cancer NeoplasmsBelgium
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
Gruppo Italiano per lo studio dei Carcinomi dell...Regione LombardiaTerminatedMetastatic Gastric Cancer | Locally Advanced Unresectable Gastric CancerItaly
-
University of Milano BicoccaRecruitingAdvanced Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerItaly
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
Samsung Medical CenterCompletedHER2-positive Gastric Cancer Patients With Liver MetastasisKorea, Republic of
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Henan Cancer HospitalNot yet recruitingAdvanced Breast Cancer | Treatment | HR Low/HER2 Negative
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingHR+/HER2- Advanced and/or Metastatic Breast Cancer
-
PfizerCompletedHR+/HER2- Locally Advanced, Metastatic Breast CancerUnited Kingdom
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic Gastroesophageal Junction CarcinomaChina
-
Novartis PharmaceuticalsCompletedHR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerCanada
-
Laura M. Spring, MDMerck Sharp & Dohme LLC; Translational Breast Cancer Research Consortium; Breast...RecruitingTriple Negative Breast Cancer | Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | Biopsy-proven, Positive Lymph Node(s)United States
-
Gustave Roussy, Cancer Campus, Grand ParisEuropean CommissionCompletedUntreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast CancerFrance
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
Reshma L. Mahtani, D.O.Gilead SciencesNot yet recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast CancerUnited States
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead SciencesActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | HR-Positive Breast CancerUnited States
-
Fudan UniversityUnknownMetastatic Gastric Cancer | Locally Advanced Gastric AdenocarcinomaChina
-
Institut für Klinische Krebsforschung IKF GmbH...RecruitingAdvanced Gastric or EGJ CancerGermany, Austria, Italy
-
The First Affiliated Hospital of Zhengzhou UniversityBeiGene; Jiangsu Hengrui Pharmaceutical Co., Ltd.; RemeGen Co., Ltd.Not yet recruitingHER2-positive or Mutated Advanced Colorectal Cancer
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownRecurrent Gastric Cancer | Advanced Metastatic Gastric CancerKorea, Republic of
-
Lin ChenRecruitingEfficacy | Safety | HER2 Negative | Locally Advanced Gastric CarcinomaChina
-
Shandong Golden Brick Biotechnology Co., Ltd.UnknownAdvanced Gastric Cancer | Gastroesophageal CancerChina